Advances in Fine Needle Aspiration Cytology for Lung Cancer Diagnosis
Author Information
Author(s): Adnan Hasanovic, Natasha Rekhtman, Carlie S. Sigel, Andre L. Moreira
Primary Institution: Memorial Sloan-Kettering Cancer Center
Hypothesis
Fine needle aspiration biopsy (FNAB) can accurately diagnose and classify pulmonary carcinomas.
Conclusion
FNAB is a reliable and effective method for diagnosing and classifying lung cancer, providing material suitable for molecular analysis.
Supporting Evidence
- FNAB has a sensitivity for lung cancer diagnosis ranging from 56% to over 90%.
- Specificity of FNAB is close to 100%, with a positive predictive value of nearly 99%.
- Immediate on-site assessment during FNAB significantly increases diagnostic accuracy.
- High concordance rates between cytology and resected specimens for NSCLC subtyping were observed.
Takeaway
Doctors can use a small needle to take samples from lung tumors to find out what type of cancer it is and how to treat it.
Methodology
The study reviews current concepts in FNAB, including its accuracy, classification, and use of ancillary techniques.
Potential Biases
Potential bias may arise from the reliance on cytological interpretation and the variability in sample quality.
Limitations
The accuracy of FNAB can be affected by factors such as poor differentiation of tumors and scant cellularity.
Participant Demographics
The study does not specify participant demographics.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website